ZBIO - Zenas Biopharma Inc.
18.01
-0.580 -3.220%
Share volume: 535,232
Last Updated: 04-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$18.59
-0.58
-0.03%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 11-12-2024 | 03-11-2025 | 05-15-2025 | 11-12-2025 | 03-16-2026 | |
| Assets | ||||||
| Total Assets | 403.432 M | 369.968 M | 333.766 M | 322.018 M | 383.640 M | |
| Current Assets | 393.778 M | 355.923 M | 317.807 M | 296.642 M | 351.171 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 26.761 M | 31.024 M | 115.825 M | 175.319 M | 232.551 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 360.038 M | 319.742 M | 196.554 M | 115.565 M | 110.641 M | |
| Total Non-current Assets | 0.000 | 0.000 | 1.835 M | 10.717 M | 17.272 M | |
| Property Plant Equipment | 146.000 K | 185.000 K | 72.000 K | 50.000 K | 34.000 K | |
| Other Assets | 9.508 M | 13.860 M | 15.887 M | 25.326 M | 32.435 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 403.432 M | 369.968 M | 333.766 M | 322.018 M | 383.640 M | |
| Total liabilities | 43.997 M | 57.510 M | 49.449 M | 125.590 M | 141.496 M | |
| Total current liabilities | 43.997 M | 57.292 M | 49.132 M | 52.421 M | 62.649 M | |
| Accounts Payable | 15.082 M | 17.136 M | 20.018 M | 6.444 M | 7.111 M | |
| Other liabilities | 0.000 | 218.000 K | 317.000 K | 180.000 K | 211.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 72.989 M | 78.636 M | |
| Other liabilities | 0.000 | 218.000 K | 317.000 K | 180.000 K | 211.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 359.435 M | 312.458 M | 284.317 M | 196.428 M | 242.144 M | |
| Common stock | 694.167 M | 699.655 M | 705.140 M | 721.183 M | 1.007 B | |
| Retained earnings | -334.786 M | -387.391 M | -420.964 M | -524.686 M | -765.128 M |